pSivida Corp.
(NASDAQ : PSDV)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
Loading PSDV News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
0.06%69.331.0%$931.92m
AMGNAmgen Inc.
0.26%173.590.8%$658.20m
BIIBBiogen Inc.
0.07%287.100.9%$536.99m
CELGCelgene Corporation
0.09%119.551.0%$480.43m
REGNRegeneron Pharmaceuticals, Inc.
-0.37%370.241.9%$347.10m
ALXNAlexion Pharmaceuticals, Inc.
1.19%131.442.0%$303.15m
TSROTESARO, Inc.
0.40%191.0315.3%$199.78m
INCYIncyte Corporation
-0.07%122.282.3%$170.01m
ILMNIllumina, Inc.
0.49%162.953.9%$148.75m
VRTXVertex Pharmaceuticals Incorporated
0.15%86.682.6%$140.28m
CLVSClovis Oncology, Inc.
0.54%63.3316.4%$133.08m
EXELExelixis, Inc.
-1.86%22.685.5%$129.03m
AAgilent Technologies, Inc.
0.33%51.521.7%$117.65m
ACADACADIA Pharmaceuticals Inc.
-0.08%39.1719.0%$93.76m
BMRNBioMarin Pharmaceutical Inc.
0.01%90.254.0%$89.99m

Company Profile

pSivida Corp. develops tiny, sustained-release products, which are designed to deliver drugs and biologics at a controlled and steady rate for weeks, months or years. The company through its technology platforms Duraser and Tethadur is focused on treatment of chronic diseases of the back of the eye and are also exploring applications outside ophthalmology. It is also developing a bioerodible, injectable micro-insert delivering latanoprost to treat glaucoma and ocular hypertension. pSivida was founded by Roger Aston in March 2008 and is headquartered in Waterson, MA.